Resumen de Longitudinal trends and variation in antipsychotic use in older adults after cardiac surgery
Dae Hyun Kim, Mufaddal Mahesri, Brian T. Bateman, Krista F. Huybrechts, Sharon K. Inouye, Edward R. Marcantonio, Shoshana J. Herzig, E. Wesley Ely, Margaret A. Pisani, Raisa Levin, Jerry Avorn
Objectives To evaluate temporal trends and between‐hospital variation in off‐label antipsychotic medication (APM) use in older adults undergoing cardiac surgery.
Design Retrospective cohort study.
Setting National administrative database including 465 U.S. hospitals.
Participants Individuals aged 65 and older without known indications for APMs who underwent cardiac surgery from 2004 to 2014 (N=293,212).
Measurements Postoperative exposure to any APMs and potentially excessive dosing were examined. Hospital‐level APM prescribing intensity was defined as the proportion of individuals newly treated with APMs in the postoperative period.
Results The rate of APM use declined from 8.8% in 2004 to 6.2% in 2014 (p<.001). Use of haloperidol (parenteral 7.0% to 4.5%, p<.001; oral: 1.9% to 0.5%, p<.001), and risperidone (1.1% to 0.3%, p<.001) declined, whereas quetiapine use tripled (0.6% to 1.9%, p=.03). Hospital APM prescribing intensity varied widely, from 0.3% to 35.6%, across 465 hospitals. Treated individuals at higher‐prescribing hospitals were more likely to receive APMs on the day of discharge (highest vs lowest quintile: 15.1% vs 9.6%; p<.001) and for a longer duration (4.8 vs 3.7 days; p<.001) than those at lower‐prescribing hospitals. Delirium was the strongest risk factor for APM exposure (odds ratio=9.73, 95% confidence interval=9.02–10.5), whereas none of the hospital characteristics were significantly associated. The rate of potentially excessive dosing declined (60.7% to 44.9%, p<.001), and risk factors for potentially excessive dosing were similar to those for any APM exposure.
Conclusions Our findings suggest highly variable prescribing cultures and raise concerns about inappropriate use, highlighting the need for better evidence to guide APM prescribing in hospitalized older adults after cardiac surgery.
